Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8836644 | Surgery | 2018 | 8 Pages |
Abstract
Readmission rates and costs for patients with a ventricular assist device remain greater than their orthotopic heart transplantation counterparts. Given the projected increases in ventricular assist device utilization and limited transplant donor pool, further emphasis on cost containment and decreased readmissions for patients undergoing a ventricular assist device is essential to the viability of such therapy in the era of value-based health care delivery.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Laith BA, Aditya MS, Esteban BS, Yas MD, Yen-Yi MD, MPH, Boback MD, PhD, Richard J. MD, Peyman MD, FACS,